Eberconazole nitrate. Antifungal

Drugs of the Future

Volumn 21, Issue 8, 1996, Pages 792-793

  Rabasseda, X ^a   Castaner J ^a   Font, E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BIFONAZOLE; CLOTRIMAZOLE; EBERCONAZOLE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CANDIDA ALBICANS; CANDIDIASIS; DERMATOMYCOSIS; DOG; DRUG SAFETY; DRUG SYNTHESIS; GRAM POSITIVE BACTERIUM; GUINEA PIG; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SHORT SURVEY; TINEA CORPORIS; TINEA CRURIS; TOPICAL DRUG ADMINISTRATION;

EID: 0029963428     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1996.021.08.364479     Document Type: Short Survey

References (11)

1. Andreoli, R., Cepero Mestres, R. (Soc. Española Esp. FarmacoTer. SA). Dichlorosubstd imidazote derivs. as antifungal agents. AU 9052554, EP 392326, US 5177099.
2. Torres-Rodríguez, J.M. New topical antifungal drugs. Arch Med Res 1993,24:371-5.
3. Torres-Rodriguez, J. M., Urrea-Arbeláez, A. New topical antifungals. Rev Esp Quimioter 1992, 5: 343-8.
4. Font, E., Freixes, J., Julve, J. Profile of a new topical antimycotic, eberconazole. Rev Iberoamer Micol 1995,12:16-7.
5. Torres-Rodríguez, J.M., Carrillo, A., Gallach, C., Madrenys, N., Juive, J. In vitro activity of WAS-2160 and WAS-2163: Two new antifungal agents, compared with clotrimazole and bifonazole for yeast and dermatophytes. Rev Iberoamer Micol 1988,5(Suppl. 1): Abst P-133.
6. Tomás, J.M., Camprubí, S., Merino, S., Parés, R., Llauradó, X., Juive, J. Inhibition of two imidazole antimycotics, eberconazole and clotrimazole, by different components of Candida albicans serotype B membrane protoplasts, Int J Antimicrob Agents 1993, 3: 61-4.
7. Font, E., Freixes, J., Llauradó, X., Julve, J., Andreoli, R. Complement activities and texicological profile of a new topical antifungal eberconazole. Farmacol Clin Exp 1993, Special Issue: Abst 25-A.
8. del Palacio, A., Cuétara, S., Rodríguez-Noriega, A. Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS-2160) cream 1% and 2%: A phase II dose-finding pilot study. Mycoses 1995, 38: 317-24.
9. Font, E., del Palacio, A., Cuétara, S., Rodriguez-Noriega, A., López, S,. Iglesias, L., Wassermann, C.I. A phase II dose-finding pilot study: Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS-2160) cream. Meth Find Exp Clin Pharmacol 1995,17(Suppl. A): Abst CO-54.
10. del Palació, A., Cuétara, S., Rodríguez-Noriega, A., López, S., Iglesias, L. A phase II dose-finding study: Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS-216S) cream. 31st Annu Meet Brit Soc Med Mycol (April 9-11, Cambridge) 1995.
11. del Palacio, A., Cuétara, S., Rodriguez-Noriega, A., López, S., Iglesias, L. A phase II dose finding pilot study: Topical treatment of tinea corporis and tinea cruris with eberconazole (WAS 2160) cream. 2nd Meet Eur Confed Med Mycol (April 27-29, Brussels) 1995, Abst.